A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Volume: 382, Issue: 19, Pages: 1787 - 1799
Published: May 7, 2020
Abstract
No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fraction of inspired...
Paper Details
Title
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Published Date
May 7, 2020
Volume
382
Issue
19
Pages
1787 - 1799
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History